Related Experiment Videos
Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction
1Departments of Gastroenterology, Hospital Universitario La Fe, Valencia, Spain.
Hepatology (Baltimore, Md.)
|August 1, 1995
Summary
Hepatitis C virus (HCV) RNA presence in apparently healthy blood donors correlates with liver disease severity. Most anti-HCV-positive donors showed histological abnormalities, with higher HCV RNA detection rates in more severe liver conditions.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) infection is a significant public health concern.
- Early detection and understanding of disease progression in blood donors are crucial for transfusion safety.
- The correlation between HCV viremia and liver histology in asymptomatic individuals requires further elucidation.
Purpose of the Study:
- To investigate the relationship between HCV viremia and the severity of liver disease.
- To assess histological liver abnormalities in anti-HCV-positive blood donors.
- To determine if HCV RNA presence correlates with liver injury markers in this population.
Main Methods:
- Study included 98 anti-HCV-positive blood donors.
- Methods included liver biopsy, serum HCV RNA detection via PCR, and liver injury tests.
- Histological findings were categorized, and HCV RNA levels were correlated with disease severity and ALT levels.
Main Results:
- 97% of donors exhibited histological liver abnormalities.
- HCV RNA was detected in 65% of donors, with higher prevalence in those with chronic active hepatitis (87%) compared to minimal changes (36%).
- HCV RNA-positive donors had a significantly higher incidence of chronic hepatitis (88% vs. 50%).
Conclusions:
- HCV viremia is strongly associated with the severity of liver disease in anti-HCV-positive blood donors.
- Liver biopsy remains essential for assessing disease stage in these individuals.
- The findings highlight the importance of screening blood donors for HCV to prevent transmission and manage potential liver disease.